Directorate

- Prof. Dr. Kashif Shafique
- Designation
- Professor (Public Health) & Principal SPH & Director ORIC
- Department
- Office of Research Innovation & Commercialization (ORIC)
- Qualification
PhD (Public Health),
MPH, Institute of Health and Wellbeing, Public Health, University of Glasgow, United Kingdom.
MBBS, Dow Medical College, University of Karachi, Pakistan- k.shafique@duh.edu.pk
- Phone Extension
- 2640
- Office Location
- School of Public Health (SPH) (2nd FLOOR), Gulzar-e-Hijri Scheme 33, Ojha Campus, DUHS
Research Interest
Chronic diseases, epidemiology, health risk behaviors & nutritional behaviors.
Research Publications
Others
Awards and Distinctions:
- Visiting Clinical Senior Lecturer (2013-2022) at the Institute of Health & Wellbeing, University of Glasgow, United Kingdom.
- Appointed as an adjunct faculty for the Khyber Medical University (2022).
- Best University Teacher Award by the Higher Education Commission of Pakistan -2016.
- Award “50 for 50” of “Future Cancer Research Leader” by the International Agency for Research on Cancer (IARC) and participated at Empowering, France 2016.
- The Global competition of young scientists to attend the 64th Lindau Nobel Laureates Meeting, at Lindau, Germany 2014.
- The “Early Career Award” from International Society of Behavioral Medicine, 2014
- Scholarship by Groningen University for a research project in Netherlands for two weeks
- Scholarship for Master and PhD studies from the Higher Education Commission of Pakistan at the University of Glasgow
Major Research Grants/Projects:
- Research Institute, National Institute of Health (NIH) on the study titled "Development of Gestational Diabetes Mellitus (GDM) Management App for Pakistani Pregnant Women: A Randomized Control trial to evaluate the impact of App use on maternal health and pregnancy outcomes as Principal Investigator for 2.1 million (PKR) in 2022
- Mental health capacity-building for primary healthcare providers to promote good health & well-being funded by Conservation Food and Health Foundation (USA) for USD 20,000 in 2022.
- Metabolic Syndrome and Risk for Cardiovascular Disease in Apparently Healthy Subsets of Pakistani Adult Population funded by Health Research Institute and Sindh Higher Education Commission of Pakistan for PKR 6 million in 2022.
- Assessment of Extent of Rational Drug Use among Patients and Healthcare Providers by Multinational Pharmaceuticals as Co-Principal Investigator for 1.2 million (PKR) in 2021.
- The Burden of MultIMorbidity, its Patterns and Consequences on Health and Well Being: The IMPACT Study. Funded by Multinational Pharmaceuticals Company as Principal Investigator in 2019.